Clonidine: Difference between revisions

Line 1:

{{headerpanel|{{proofread}}{{Approval}}}}

'''Clonidine''' (also known by the trade names '''Catapres''', '''Kapvay''', '''Nexiclon''', '''Clophelin''', and others) is a medication used to treat high blood pressure, attention deficit hyperactivity disorder, anxiety disorders, tic disorders, withdrawal (from either alcohol, opioids, or smoking), migraine, menopausal flushing, diarrhea, and certain pain conditions.<ref>Brayfield, A, ed. (13 January 2014). "Clonidine". Martindale: The Complete Drug Reference. London, UK: Pharmaceutical Press. Retrieved 28 June 2014.</ref> It is classified as a centrally acting α2 adrenergic agonist and imidazoline receptor agonist. It has been in clinical use for over 40 years.<ref>Neil, MJ (November 2011). "Clonidine: clinical pharmacology and therapeutic use in pain management.". Current Clinical Pharmacology. 6 (4): 280–7. PMID 21827389.</ref>

'''Clonidine''' (also known by the trade names '''Catapres''', '''Kapvay''', '''Nexiclon''', '''Clophelin''', and others) is a medication used to treat [[increased blood pressure|high blood pressure]], attention deficit hyperactivity disorder, [[anxiety]] disorders, tic disorders, [[drug withdrawal|substance withdrawal]] (from either [[alcohol]], [[opioids]], or smoking tobacco), migraine, menopausal flushing, [[diarrhea]], and certain pain conditions.<ref>Brayfield, A, ed. (13 January 2014). "Clonidine". Martindale: The Complete Drug Reference. London, UK: Pharmaceutical Press. Retrieved 28 June 2014.</ref> It is classified as a centrally acting α2 [[adrenergic]] [[agonist]] and imidazoline [[receptor]] [[agonist]]. It has been in clinical use for over 40 years.<ref>Neil, MJ (November 2011). "Clonidine: clinical pharmacology and therapeutic use in pain management.". Current Clinical Pharmacology. 6 (4): 280–7. PMID 21827389.</ref>

==Chemistry==

@@ Line 1: / Line 1: @@
 {{headerpanel|{{proofread}}{{Approval}}}}
 {{SubstanceBox/clonidine}}
-'''Clonidine''' (also known by the trade names '''Catapres''', '''Kapvay''', '''Nexiclon''', '''Clophelin''', and others) is a medication used to treat high blood pressure, attention deficit hyperactivity disorder, anxiety disorders, tic disorders, withdrawal (from either alcohol, opioids, or smoking), migraine, menopausal flushing, diarrhea, and certain pain conditions.<ref>Brayfield, A, ed. (13 January 2014). "Clonidine". Martindale: The Complete Drug Reference. London, UK: Pharmaceutical Press. Retrieved 28 June 2014.</ref> It is classified as a centrally acting α2 adrenergic agonist and imidazoline receptor agonist. It has been in clinical use for over 40 years.<ref>Neil, MJ (November 2011). "Clonidine: clinical pharmacology and therapeutic use in pain management.". Current Clinical Pharmacology. 6 (4): 280–7. PMID 21827389.</ref>
+'''Clonidine''' (also known by the trade names '''Catapres''', '''Kapvay''', '''Nexiclon''', '''Clophelin''', and others) is a medication used to treat [[increased blood pressure|high blood pressure]], attention deficit hyperactivity disorder, [[anxiety]] disorders, tic disorders, [[drug withdrawal|substance withdrawal]] (from either [[alcohol]], [[opioids]], or smoking tobacco), migraine, menopausal flushing, [[diarrhea]], and certain pain conditions.<ref>Brayfield, A, ed. (13 January 2014). "Clonidine". Martindale: The Complete Drug Reference. London, UK: Pharmaceutical Press. Retrieved 28 June 2014.</ref> It is classified as a centrally acting α2 [[adrenergic]] [[agonist]] and imidazoline [[receptor]] [[agonist]]. It has been in clinical use for over 40 years.<ref>Neil, MJ (November 2011). "Clonidine: clinical pharmacology and therapeutic use in pain management.". Current Clinical Pharmacology. 6 (4): 280–7. PMID 21827389.</ref>
 ==Chemistry==